We are a team of medical professionals, devoted to cancer care for many years. The Institute of Cellular Therapies Pvt. Ltd. was established in the year 2006 and since then is actively engaged in administering safe and effective dendritic cell treatment to numerous cancer patients. The idea is to make the treatment affordable and accessible to a large patient population.
"Greater number of patients should be benefited from high quality meaningful research."
He has done maximum number of dendritic cell therapies in the world during the last five years of clinical practice making more than 3000 denvax doses for about 500 patients. He has developed a world class clean room facility (class 100) for cell culture. Along with cell therapy the laboratory is equipped with COBE Spectra apheresis system for making multiple doses of dendritic cells and completing the manufacturing protocol in one sitting.
He is member of American Association of Cancer Research and Indian Medical Association.
He is involved in various ongoing researches that can improve life of cancer patients.
He speaks in various cancer care organizations and organizes various seminars for educating cancer patients and medical doctors about the importance of cancer immunotherapy.
He works eight days in the lab and 365 days in a year to give maximum comfort to his patients by providing them the best product for their cancer treatment.
"Greater number of patients should be benefited from high quality meaningful research."
Dr. Jamal A. Khan (Director, Institute of Cellular Therapies)
Dr. Jamal A. Khan has done his medical education (MBBS) and post graduation (MD) from Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh (U.P.). He was Lecturer in the alma mater for seven years before quitting the job for promoting the work of cancer immunotherapy. Besides publishing pioneering work from India he has attended various national and international seminars in Oncology.He has done maximum number of dendritic cell therapies in the world during the last five years of clinical practice making more than 3000 denvax doses for about 500 patients. He has developed a world class clean room facility (class 100) for cell culture. Along with cell therapy the laboratory is equipped with COBE Spectra apheresis system for making multiple doses of dendritic cells and completing the manufacturing protocol in one sitting.
He is member of American Association of Cancer Research and Indian Medical Association.
He is involved in various ongoing researches that can improve life of cancer patients.
He speaks in various cancer care organizations and organizes various seminars for educating cancer patients and medical doctors about the importance of cancer immunotherapy.
He works eight days in the lab and 365 days in a year to give maximum comfort to his patients by providing them the best product for their cancer treatment.